China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China flag China · Delayed Price · Currency is CNY
20.89
-0.32 (-1.51%)
Mar 9, 2026, 3:04 PM CST

China Resources Boya Bio-pharmaceutical Group Co.,Ltd Company Description

China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the blood product businesses in China.

It offers blood products, such as human coagulation, human prothrombin, human fibrinogen, human albumin, intravenous human immunoglobulin, and rabies immunoglobulin; and non-blood products.

The company also provides bone peptide, oxytocin, heparin sodium, and posterior pituitary injection products.

In addition, it engages in research, development, production, and sales of anti-infective, diabetes, and cardiovascular drug; and distributes blood products.

The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co.,Ltd. The company was founded in 1993 and is based in Fuzhou, China.

China Resources Boya Bio-pharmaceutical Group Co.,Ltd
Country China
Founded 1993
Industry Biotechnology
Sector Healthcare
Employees 1,938
CEO Xiaoming Liang

Contact Details

Address:
No. 333, Huiquan Road
Fuzhou, 344000
China
Phone 86 79 4822 1448
Website china-boya.com

Stock Details

Ticker Symbol 300294
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100001FF1
SIC Code 2836

Key Executives

Name Position
Xiaoming Liang President and Director
Huacheng Liang Vice President, Chief Financial Officer, Secretary and Director
Hui Ren Vice President and Director
Bing Chen Vice President
Shousun Ii Vice President
Shuanhong Zhang Vice President
Zi He Wang Accounting Supervisor
Qian Qian Yan Compliance Manager and Employee Representative Supervisor